Obesity

Nutritional strategies for correcting low glucose values in patients with postbariatric hypoglycaemia: A randomized controlled three‐arm crossover trial

Diabetes Obes MetabPublished Randomised controlled trial

Authors' conclusion

Correcting hypoglycaemia with 15 g of glucose should be reconsidered in post-RYGB PBH. A lower dose appears to sufficiently increase glucose levels outside the critical range in most cases, and complementary nutrients (e.g. proteins) may provide glycaemia-stabilizing benefits.

Study context

Population
Post-RYGB adults with postbariatric hypoglycaemia (mean [SD] 7.0 [1.4] years since surgery); hypoglycaemia induced by solid mixed meal, corrected at plasma glucose <3.0 mmol/Lcrossover
Participants
8 adults
Comparison
Hypoglycaemia correction with 15 g glucose vs 5 g glucose vs protein bar
Primary endpoint
Percentage of time in target plasma glucose range (3.9-5.5 mmol/L)
Follow-up
40 minutes after correction
Methodological detailsthree-arm crossover
  • Three-arm crossover

Primary result

As reported in the abstract

Time in target glucose range (3.9-5.5 mmol/L) · 40 minutes postcorrection
  • Did not differ significantly between the interventions
  • Between G15 and G5: P = 0.161

Further findings

OutcomeP value
Postcorrection time with glucose <3.9 mmol/LG15 vs P10 · lower after G15P = 0.007
Glucagon 15 min postcorrection · 15 minutes postcorrectionP10 vs G15 · higher after P10P = 0.002
Glucagon 15 min postcorrection · 15 minutes postcorrectionP10 vs G5 · higher after P10P = 0.003

Time with glucose >5.5 mmol/L, peak glucose and insulin 15 min postcorrection

Higher after G15 than G5 and P10
P < 0.001

Safety

Rebound hypoglycaemia (< 3.0 mmol/L) — G15
38%
  • Rebound hypoglycaemia (< 3.0 mmol/L): three of eight cases with G15

Rebound hypoglycaemia (< 3.0 mmol/L)

No rebound hypoglycaemia occurred with G5 and P10

Original publication

Nutritional strategies for correcting low glucose values in patients with postbariatric hypoglycaemia: A randomized controlled three‐arm crossover trial. Diabetes Obes Metab. Published 19 June 2023. doi:10.1111/dom.15175

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.